| PERIOD ENDING | 2-Nov-09 | 10-Aug-09 | 18-May-09 | 26-Jan-09 | | Total Revenue | 324,217 | 335,967 | 446,804 | 327,454 | | Cost of Revenue | 19,637 | 266,369 | 354,201 | 264,956 | | | Gross Profit | 304,580 | 69,598 | 92,603 | 62,498 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 49,678 | 45,976 | 61,880 | 47,275 | | Non Recurring |
-
| 1,359 | 916 | 1,473 | | Others |
-
| 95 | 132 |
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 16,262 | 22,168 | 29,675 | 13,750 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 704 | 425 | 862 | 788 | | Earnings Before Interest And Taxes | 16,966 | 22,593 | 30,537 | 14,538 | | Interest Expense | 6,430 | 2,060 | 6,344 | 12,279 | | Income Before Tax | 10,536 | 20,533 | 24,193 | 2,259 | | Income Tax Expense | 4,379 | 8,283 | 9,798 | (349) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 6,157 | 12,250 | 14,395 | 2,608 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 6,157 | 12,250 | 14,395 | 2,608 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $6,157 | $12,250 | $14,395 | $2,608 |
|
0.01% Nasdaq 
Income Statement
